Farmako ApS: Financial statements 2020
CVR: 40143548
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Farmako ApS (CVR 40143548) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -26,930 and a net result of DKK -26,930 compared with DKK -28,974 the year before. Equity in the 2020 report amounted to DKK -5,904.
- Gross Profit
- DKK -26,930
- Profit/Loss
- DKK -26,930
- Equity
- DKK -5,904
- Total Assets
- DKK 6,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -27 t. | -27 t. | -6 t. | - |
| 2019 | - | -29 t. | -29 t. | 21 t. | - |
Official annual report
How creditworthy is Farmako ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Farmako ApS has published its annual report for 2019. Gross profit came to DKK -28,970, and the net result was DKK -28,974.
As of March 24, 2020, Katrin Eckmans is registered as director of Farmako ApS.
As of March 24, 2020, Andreas Karl Matthias Jägle has stepped down as director of Farmako ApS.
About Farmako ApS
Farmako ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2019. The company has been dissolved. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2024, the company reported a gross profit of DKK -15,750 and a net result of DKK -15,749 compared with DKK -16,875 the year before. Equity in the 2024 report amounted to DKK -65,153.